Unexpected high testis-specific transcriptional activity of the cyclin T1 promoter in transgenic mice  by Mata, X et al.
Unexpected high testis-speci¢c transcriptional activity of
the cyclin T1 promoter in transgenic mice
X. Mataa;, N. Besnarda, K. Le Rouxa, G. Tillya, O. Andre¤olettib, M. Hudrisiera,
J. Costa Da Silvaa, H. Laudec, J.L. Vilottea
aLaboratoire de Ge¤ne¤tique Biochimique et de Cytoge¤ne¤tique, INRA, 78352 Jouy-en-Josas Cedex, France
bUMR INRA-ENV Toulouse: Physiopathologie infectieuse et parasitaire des ruminants, ENVT, 23, Chemin des Capelles, 31076 Toulouse Cedex,
France
cUnite¤ de Virologie Immunologie Mole¤culaires, INRA, 78352 Jouy-en-Josas Cedex, France
Received 2 May 2003; revised 30 June 2003; accepted 2 July 2003
First published online 25 July 2003
Edited by Hans-Dieter Klenk
Abstract The ubiquitously expressed cyclin T1 gene encodes
for a protein involved in human immunode¢ciency virus type 1
(HIV-1) transcription activation. The goat gene was recently
shown to share an expression pattern similar to that of its
endogenous counterpart when incorporated into mice using a
BAC insert. To assess if its promoter could target ubiquitous
expression of the bovine Prnp in transgenic mice, two constructs
carrying either 1 or 30 kb of cyclin T1 5P-£anking sequences
were built and microinjected. Both constructs resulted in the
unexpected high male germ cell-speci¢c expression of the prion
protein. These data re-question the suspected location of the
cyclin T1 gene regulatory elements.
, 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The cyclin T1 (CycT1) protein was identi¢ed as being a
cofactor for the human immunode¢ciency virus type 1
(HIV-1) Tat protein, in association with the cyclin-dependent
kinase-9 (CDK-9) [1,2]. This complex is involved in the RNA
polymerase II transcription elongation. Indeed, binding of Tat
to CycT1 induces cooperative binding of the positive tran-
scription elongation factor complex, P-TEFb, onto nascent
HIV-1 transcription response element (TAR) RNA [3]. The
interaction of the Tat protein strongly increases the a⁄nity
and speci¢city of the Tat protein for TAR, making a stable
RNA stem-loop structure at the 5P-end of nascent viral tran-
scripts [1,2,4]. Inhibition of the P-TEFb complex can involve
the binding of the 7SK small nuclear RNA [5,6] while CycT1
itself was shown to be implicated in the ubiquitination and
degradation of CDK-9 [7].
The human, murine and goat CycT1 genes are known to
have a ubiquitous expression [8^12]. Functional analysis of
the human promoter in cell cultures suggested that its activity
resides in the 545 nucleotides upstream to the translation
initiation site [8,12] while expression in transgenic mice of
the goat gene, alongside 30 kb and about 90 kb of 5P- and
3P-£anking sequences (BAC 41), respectively, was shown to be
ubiquitous [13].
To further assess the potentiality of this promoter in vivo, a
short (1 kb) and a long (30 kb) promoter of the goat CycT1
gene was used to express a bovine Prnp cDNA in Prnp knock-
out mice. Because of the ubiquitous reported transcriptional
activity of this gene, creation of mice expressing the bovine
prion protein in most if not all of their cells was expected.
Such animals could in return be useful models to study bovine
spongiform encephalopathy (BSE), as it is now well docu-
mented that PrP is a major determinant of the species barrier
in transmissible spongiform encephalopathy (TSE) transmis-
sion [14^18].
An unexpected high testis expression of the bovine Prnp
was observed in transgenic mice carrying either transgenes.
Occurrence of the prion protein was only observed in the
germ cells. These results suggest that some cis-regulatory ele-
ments involved in the transcriptional regulation of the CycT1
gene are located within the transcription unit of this gene and/
or its 3P-£anking region.
2. Materials and methods
2.1. Construction of the transgenes
Two overlapping fragments were polymerase chain reaction (PCR)
ampli¢ed: one containing the entire bovine six octarepeats Prnp open
reading frame (ORF) (using oligonucleotides 5P-GACGCCGAGA-
AGTGCTTGCAGCCGCCGCCGCTGCCTTCTGGTTGAAGCAC-
TATGGTGAAAAGCCACATAGG-3P and 5P-GCTTGGTCGAC-
CTGATACTTCCCG-3P and the corresponding cloned cDNA as
template) and the second corresponding to about 1 kb of the goat
CycT1 promoter region and the 5P-untranslated region (UTR) of the
cDNA (using oligonucleotides 5P-TGCATTGTCGACGGAAATGG-
CAACCC-3P and 5P-ATGTGGCTTTTCACCATAGTGCTTCAAC-
CAGAAGGC-3P and the cloned CycT1 gene as template). These
two fragments were joined together in a third PCR made with the
puri¢ed ampli¢ed products and the oligonucleotides 5P-GCTTGGT-
CGACCTGATACTTCCCG-3P and 5P-TGCATTGTCGACGGAA-
ATGGCAACCC-3P. The ampli¢ed DNA, named CRG11, was di-
gested with SalI, cloned into the corresponding site of pUC19 and
sequenced. The CRG11 insert was puri¢ed out of the plasmid follow-
ing a SacI restriction digest.
The 3P-end (exons V^VII) of the sheep L-lactoglobulin gene and its
3P-£anking region were released from the pBJ39 recombinant plasmid
(quoted in [23], a kind gift from Dr C.B.A. Whitelaw, Roslin Institute,
Scotland) as an EcoRV/XbaI fragment and cloned into pUC19 SmaI/
XbaI. This plasmid was then digested by SacI and the CRG11 insert
cloned into it. Its orientation was assessed by an EcoRI digestion,
leading to the CRLLg2 plasmid. Prior to microinjection, the A con-
struct was released by a SalI digestion of this plasmid and gel puri¢ed.
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The SalI-A insert was subcloned into the pSV1RecA plasmid and
inserted by homologous recombination into the BAC 41 [13], follow-
ing previously described procedures [24]. Recombinant BAC clones
were analysed by Southern blotting analyses of their DNA and the
B construct gel puri¢ed out of them following a NotI/SalI double
digest prior to its microinjection.
2.2. Generation of transgenic mice
Transgenic founders were obtained by pronuclear microinjection of
the constructs into FVB/N Prnp0=0 (knockout) mouse eggs (a kind gift
from Dr S. Prusiner, University of California, San Francisco, CA,
USA), using standard procedures. Transgenic mice were identi¢ed
by PCR using oligonucleotides 5P-GCTCACCTAGACGTGG-
CACTG-3P, located within sheep L-lactoglobulin gene exon VI
(Fig. 1) and 5P-CTTTCCTCATTTTTCTCATAGTAG-3P, located
within the bovine ORF cDNA (Fig. 1), with 40 cycles: 30 s at
94‡C, 30 s at 60‡C, 30 s at 72‡C. Southern blot analysis on PstI-
digested genomic DNA of G1 mice was performed to assess the num-
ber of copies of the transgene integrated in the di¡erent lines using a
bovine Prnp cDNA as probe.
2.3. Transgene expression analysis
Northern and Western blot analyses were performed as previously
described [19] using anti-PrP antibodies 18 (a kind gift from Dr S.
Hawke, Imperial College, London, UK). Immunohistochemical anal-
ysis of cellular PrP distribution in testis was performed using anti-PrP
antibodies 12F10 [20], as described [21]. For reverse transcription
(RT)-PCR experiments, the RT step was performed on 5 Wg of DNase
I-treated total RNA using oligonucleotide 5P-GAAGGAGAAGCT-
GCCCAGAGC-3P, located within exon VII of the sheep L-lactoglo-
bulin gene (Fig. 1), while the PCR step was as described for the
identi¢cation of the transgenic mice (data not shown). Since one of
the oligonucleotides is located within the bovine ORF cDNA while
the second is complementary to part of the sheep L-lactoglobulin gene
exon VI (Fig. 1), the size of the ampli¢ed fragment will discriminate
between DNA contamination and RT mRNA products.
3. Results and discussion
3.1. Testis prevalence transcriptional activity of a short goat
CycT1 promoter in transgenic mice
The bovine Prnp ORF was inserted 5P of an ovine L-lacto-
globulin polyadenylation signal and 3P of a 1 kb goat CycT1
promoter (construct A in Fig. 1a). In vitro and in silico anal-
yses suggested that the regulatory elements controlling the
CycT1 transcriptional activity are located within the proximal
CycT1 5P-£anking region [8,10,12]. Thus the promoter used in
this transgene was supposed to contain this critical region.
The construct was injected into eggs derived from mouse
Prnp knockout and 15 transgenic founders (named TgA)
were identi¢ed out of the 86 analysed pups. One female
founder was found to be sterile. This percentage of sterility
is in the range of what was previously obtained in our hands
with various other transgenes and no correlation could be
observed with the expression levels of the constructs in this
mouse (data not shown). Two lines did not transmit the trans-
gene to their progeny, re£ecting their potential mosaic status
[22].
Transgene expression was ¢rst assessed by Northern anal-
yses performed on total RNA samples from various tissues
(brain, spleen, liver, skeletal muscle, ovary, kidney, salivary
gland, heart, intestine, lung, epididymis and testis) of 5 weeks
old G1 transgenic mice. A testicular transgene expression was
observed in the nine lines while no detectable hybridisation
signal could be revealed in any of the other samples tested,
despite the loading of 20 Wg of total RNA (Fig. 1b and data
Fig. 1. Schematic representation of construct A and B and expression analysis. a: Schematic representation of A and B constructs. Light grey
box: goat CycT1 5P-£anking region and 5P-UTR. These regions cover about 1 kb in A and 30 kb in B. White box: bovine Prnp ORF. Dark
grey boxes: sheep L-lactoglobulin exons V^VII and 3P-£anking region (1.7 kb). Known locations of restriction sites are indicated. This ¢gure is
not at scale. b: Northern analysis performed using 20 Wg of total RNA and hybridised with an ovine Prnp cDNA probe. Mur, murine Prnp
signal. This expected signal results from the strategy used to knockout the Prnp locus [25]. Bov, bovine Prnp signal; B. brain; S, spleen;
T, thymus; SG, salivary gland; L, liver; M, skeletal muscle; Te, testis. Origins of the sample are indicated on the top. Crosses refer to the Tg
classi¢cation shown below. The blot was stripped and rehybridised with a mouse actin cDNA probe to assess the equal loading of the RNA
samples derived from the same tissue. c: Classi¢cation of TgA and TgB lines according to the transgene testicular expression level. N.D., not
detected.
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not shown). The number of expressing lines suggest that this
pattern of expression is due to the transgene transcriptional
activity and not to an integration site e¡ect. No signal was
visible in all analysed tissues from three other lines (data not
shown). It probably results from the integration of the trans-
gene in silent chromatin domains in these three lines.
The CycT1 gene is known to be ubiquitously expressed in
human, mouse and goat [8^11] while the goat gene was shown
to behave similarly when introduced into mice [13]. We next
assessed whether the observed testicular expression of the
transgene re£ected a tissue-restricted transcription of this
gene or its speci¢c overexpression in this tissue. To this aim,
RT-PCR experiments were performed on the RNA samples
already analysed by Northern analysis. Weak ubiquitous ex-
pression of the transgene was detected in one transgenic line
that has a moderate level of Prnp mRNA in its testis, while it
was not observed in the remaining eight lines that have lower
PrP expression levels in their testis.
This relatively low level of expression of the transgene in
tissues other than the testis could result from the location of
enhancer elements further upstream from the promoter se-
quence used in the A construct. To test this hypothesis, a
new construct with increased CycT1 5P-£anking region was
tested.
Fig. 2. Western blotting analysis of PrP expression. 50 Wg of total
testis protein extract were loaded per sample. Coomassie blue stain-
ing of the gel was also performed to con¢rm equal loading between
samples (data not shown). Origins of the sample are indicated on
the top line. Distances of migration of molecular mass markers are
indicated on the right margin. Western blot analysis was performed
as previously described [22] using anti-PrP antibodies 18 (a kind gift
from Dr S. Hawke, Imperial College, London, UK).
Fig. 3. Immunohistochemical analysis of PrP distribution in testis. Tissue sections were counterstained with hematoxylin. Speci¢c PrP germ cell
labelling is observed in TgA and TgB mice. The labelling observed in Leydig cells corresponds to background as observed in A. Immunohisto-
chemical analysis of cellular PrP distribution in testis was performed using anti-PrP antibodies 12F10 [20], as described [21]. A: FVB/N Prnp
knockout mouse. B, C: TgA.12 mouse. D^F: TgB.75 mouse. Magnitudes: D: 200U. A, B, E: 400U. C, F: 1000U.
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3.2. Increasing the length of the 5P-£anking region does not
in£uence its expression pattern
The B construct is identical to the A transgene but encom-
passes 30 kb of the 5P CycT1 £anking region (Fig. 1a). 24
transgenic founders (named TgB) were identi¢ed out of the
112 analysed pups. Two male founders were found to be
sterile and two did not transmit the transgene to their prog-
eny.
A testicular transgene expression was consistently observed
by Northern analysis in the 22 lines analysed while no detect-
able hybridisation signal could be revealed in any of the other
tissues tested (Fig. 1 and data not shown). Comparative anal-
ysis of the hybridisation signals observed in the testis revealed
various levels of expression between transgenic lines, with all
highest expressing lines belonging to the TgB group (see Fig.
1c). No correlation was detected between the number of cop-
ies of the B transgene that were integrated and the bovine
Prnp testicular expression levels, suggesting an in£uence of
the site of integration on the transcription rate despite 100%
of expressing lines (data not shown).
As in TgA lines, RT-PCR experiments were performed on
the RNA samples already analysed by Northern analysis.
Weak ubiquitous expression of gene was detected in TgB ex-
pressing high to moderate levels of Prnp in their testis, la-
belled +++ and ++ in Fig. 1c, and no expression was ob-
served but in the testis in transgenic mice labelled +.
Overall, this pattern of expression is identical to that ob-
served in TgA mice and is in sharp contrast with the one
observed in transgenic mice bearing the original BAC 41
[13]. It is unlikely that this pro¢le results from sequences
located within the Prnp cDNA and/or the 3P-region of the
sheep L-lactoglobulin since (i) non-testicular tissue-speci¢c ex-
pression of Prnp has been repeatedly achieved in mice and
(ii) the L-lactoglobulin is a mammary-speci¢c gene. It rather
strongly suggests that regulatory elements are present within
the transcription unit of the CycT1 gene or its 3P-£anking
region that enhance its expression in non-testis tissues, or in-
versely repress its testicular expression. The similarity of the
expression pattern observed in TgA and TgB mice argues for
the occurrence of some critical regulatory elements within the
proximal CycT1 5P-£anking region, as already suggested by
sequence comparisons and transfection experiments [8,10,12].
However, enhancers and/or protective sequences against posi-
tion e¡ect might reside in regions more 5P-distal to the start of
the transcription unit, explaining the overall higher level of
expression observed in TgB mice.
3.3. The testicular bovine PrP protein expression is restricted
to the germ cells
Western blot analysis performed on total testicular protein
extracts revealed the occurrence of three PrP bands in both
TgA- and TgB-expressing lines, corresponding to di¡erent
glycosylation patterns (Fig. 2 and data not shown). A more
precise biochemical characterisation of this protein will be
reported elsewhere. To further assess cellular distribution of
the transgene expression, immunohistochemical analysis was
performed. The bovine prion protein was detected on germ
cells, including spermatozoa, but not on Sertoli or Leydig cells
(Fig. 3).
Overall TgA and TgB mice demonstrate an unexpected
CycT1 promoter transcriptional activity in vivo with a
marked germ cell prevalence directed by a relatively short
5P-£anking region. These data also suggest that regulatory
elements controlling the transcriptional activity of this pro-
moter are located outside the 5P-£anking region.
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